The Role of the Reactive Oxygen Species Scavenger Agent, Astaxanthin, in the Protection of Cisplatin-Treated Patients Against Hearing Loss
Benyu Nan,1,2 Xi Gu,3 Xinsheng Huang2 1Department of Otorhinolaryngology-Head and Neck Surgery, Wenzhou Medical University, Affiliated Hospital 2, Wenzhou 325000, People’s Republic of China; 2Department of Otorhinolaryngology-Head and Neck Surgery, Zhongshan Hospital, Fudan University, Sha...
Main Authors: | Nan B, Gu X, Huang X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-role-of-the-reactive-oxygen-species-scavenger-agent-astaxanthin-in-peer-reviewed-article-DDDT |
Similar Items
-
Regulator of G-protein Signaling 17 – A key modulator in Cisplatin-induced Hearing Loss
by: Dhukhwa, Asmita
Published: (2019) -
Prevention of cisplatin‐induced hearing loss in children: Informing the design of future clinical trials
by: Lori M. Minasian, et al.
Published: (2018-07-01) -
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
by: Sumana Ghosh, et al.
Published: (2018-08-01) -
Dose-Dependent Effects of Resveratrol on Cisplatin-Induced Hearing Loss
by: Chang Ho Lee, et al.
Published: (2021-12-01) -
Clinical aspects of hearing loss associated with cisplatin therapy – a review
by: Felician Chirteş
Published: (2014-12-01)